New Zantac Study Lends Support to Plaintiffs’ Cancer Claims

Lawsuits filed against Sanofi and Boehringer Ingelheim, manufacturer of heartburn medication Zantac, top 291 in the multidistrict litigation, and are expected to rise in the near future. Plaintiffs allege cancer injury claims stemming from ranitidine, the active ingredient in the medication. The Zantac MDL was consolidated in February 2020 in the Southern District of Florida, …

New Zantac Study Lends Support to Plaintiffs’ Cancer Claims Read More »